U.K. court backs Teva's 2015 Copaxone patent; Vertex hikes forecast on strong Kalydeco sales;

@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma

@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce

> A U.K. appeals court upheld Teva Pharmaceutical Industries' ($TEVA) May 2015 patent on its key multiple sclerosis drug Copaxone after a U.S. appeals court overturned the same patent last week. Report

> Vertex Pharmaceuticals' ($VRTX) new drug for cystic fibrosis patients, Kalydeco, handily beat analyst expectations with $99 million in quarterly sales, inspiring the company to raise its full-year forecast. Report

> Perrigo ($PRGO) shares plummeted after yesterday's announcement that it had agreed to buy the Irish drugmaker Elan ($ELN) for $8.6 billion in cash and stock, but some analysts raised their price targets. Report

> Dr. Reddy's Laboratories posted a 7.4% increase in quarterly profits, disappointing analysts, after a drop in European revenue offset increased U.S. sales. Report

Medical Device News

@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev

@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce

@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce

> Roche, Thermo unite for sepsis diagnostics. Article

> Foundation Medicine pursues $86.3M IPO. Story

> FDA's first-time PMAs down drastically so far in 2013. Item

Biotech News

@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech

@RyanMFierce: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce

@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce

> Sanofi, NEA team up in $18M round for rare disease outfit Edimer. Story

> Celgene inks $11M inflammation deal with Array BioPharma. News

> Synta Pharma rebounds on early results from drug study for breast cancer. Article

Biotech Research News

@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce

> Novavax joins H7N9 vaccine race, reports positive preclinical data. News

> Antibody effective at fighting norovirus in chimps. Story

> Novavax joins H7N9 vaccine race, reports positive preclinical data. Article

> Antibody effective at fighting norovirus in chimps. More

Pharma Manufacturing News

@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce

> Cadila Pharma selects site for $150M Russian plant. News

> Alexion adding 50 jobs in Ireland to grow global supply chain. Item

> Pfizer says investments in Ireland position plants for growth. More

> New Russian company to build $85M plant. Story

> Bristol-Myers turns to Samsung for cancer drug. Article

And Finally... Another reason to floss: Bacteria linked to gum disease moved to the brains of Alzheimer's patients, scientists said, suggesting dental hygiene may play a role in the disease. Report

Suggested Articles

Long-time trend watcher and marketer Rohit Bhargava challenged pharma marketers to adopt new habits to become non-obvious thinkers.

Samsung Biologics opened the doors to its first-ever US CDO R&D Center in San Francisco.

When the COVID-19 pandemic began, early fears of shortages of pharmaceutical supplies and drugs were quickly abated by a responsive supply chain.